These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1388667)

  • 1. An evaluation of different enzymatic cleavage methods for recombinant fusion proteins, applied on des(1-3)insulin-like growth factor I.
    Forsberg G; Baastrup B; Rondahl H; Holmgren E; Pohl G; Hartmanis M; Lake M
    J Protein Chem; 1992 Apr; 11(2):201-11. PubMed ID: 1388667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin and H64A subtilisin cleavage of fusion proteins for preparation of human recombinant parathyroid hormone.
    Forsberg G; Brobjer M; Holmgren E; Bergdahl K; Persson P; Gautvik KM; Hartmanis M
    J Protein Chem; 1991 Oct; 10(5):517-26. PubMed ID: 1799410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separation and characterization of modified variants of recombinant human insulin-like growth factor I derived from a fusion protein secreted from Escherichia coli.
    Forsberg G; Palm G; Ekebacke A; Josephson S; Hartmanis M
    Biochem J; 1990 Oct; 271(2):357-63. PubMed ID: 2173560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of des-(741-1668)-factor VIII, a single-chain factor VIII variant with a fusion site susceptible to proteolysis by thrombin and factor Xa.
    Donath MJ; de Laaf RT; Biessels PT; Lenting PJ; van de Loo JW; van Mourik JA; Voorberg J; Mertens K
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):49-55. PubMed ID: 7492334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linkers for improved cleavage of fusion proteins with an engineered alpha-lytic protease.
    Lien S; Milner SJ; Graham LD; Wallace JC; Francis GL
    Biotechnol Bioeng; 2001 Aug; 74(4):335-43. PubMed ID: 11410858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An SRLLR motif downstream of the scissile bond enhances enterokinase cleavage efficiency.
    Liew OW; Jenny Chong PC; Lim YZ; Ang CX; Amy Lau YC; Yandle TG; Brennan SO
    Biochimie; 2007 Jan; 89(1):21-9. PubMed ID: 17097793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction of spacer peptides N-terminal to a cleavage recognition motif in recombinant fusion proteins can improve site-specific cleavage.
    Polyak SW; Forsberg G; Forbes BE; McNeil KA; Aplin SE; Wallace JC
    Protein Eng; 1997 Jun; 10(6):615-9. PubMed ID: 9278273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient production of the C-terminal domain of secretory leukoprotease inhibitor as a thrombin-cleavable fusion protein in Escherichia coli.
    Masuda K; Kamimura T; Kanesaki M; Ishii K; Imaizumi A; Sugiyama T; Suzuki Y; Ohtsuka E
    Protein Eng; 1996 Jan; 9(1):101-6. PubMed ID: 9053897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enterokinase monolithic bioreactor as an efficient tool for biopharmaceuticals preparation: on-line cleavage of fusion proteins and analytical characterization of released products.
    Tengattini S; Rinaldi F; Piubelli L; Kupfer T; Peters B; Bavaro T; Calleri E; Massolini G; Temporini C
    J Pharm Biomed Anal; 2018 Aug; 157():10-19. PubMed ID: 29754038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatic and chemical cleavage of fusion proteins.
    LaVallie ER; McCoy JM; Smith DB; Riggs P
    Curr Protoc Mol Biol; 2001 May; Chapter 16():Unit16.4B. PubMed ID: 18265131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of recombinant thioredoxin fused N-terminal proCNP: Analysis of enterokinase cleavage products reveals new enterokinase cleavage sites.
    Liew OW; Ching Chong JP; Yandle TG; Brennan SO
    Protein Expr Purif; 2005 Jun; 41(2):332-40. PubMed ID: 15866719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient cleavage by alpha-thrombin of a recombinant fused protein which contains insulin-like growth factor I.
    Nishikawa S; Yanase K; Tokunaga-Doi T; Kodama K; Gomi H; Uesugi S; Ohtsuka E; Kato Y; Suzuki F; Ikehara M
    Protein Eng; 1987 Dec; 1(6):487-92. PubMed ID: 3334100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical review of the methods for cleavage of fusion proteins with thrombin and factor Xa.
    Jenny RJ; Mann KG; Lundblad RL
    Protein Expr Purif; 2003 Sep; 31(1):1-11. PubMed ID: 12963335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinase.
    Holvoet P; Laroche Y; Lijnen HR; Van Hoef B; Brouwers E; De Cock F; Lauwereys M; Gansemans Y; Collen D
    Eur J Biochem; 1992 Dec; 210(3):945-52. PubMed ID: 1483477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enterokinase cleavage of fusion proteins for preparation of recombinant human parathyroid hormone 1-34.
    Xiu ZY; Zhou HY; Yu Y; Dai JF; Chen CQ
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jul; 34(4):469-74. PubMed ID: 12098770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of des-(1-3) insulin-like growth factor-I in serum by an acid protease.
    Yamamoto H; Murphy LJ
    Endocrinology; 1994 Dec; 135(6):2432-9. PubMed ID: 7988428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant enterokinase light chain with affinity tag: expression from Saccharomyces cerevisiae and its utilities in fusion protein technology.
    Choi SI; Song HW; Moon JW; Seong BL
    Biotechnol Bioeng; 2001 Dec; 75(6):718-24. PubMed ID: 11745150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin.
    Lijnen HR; Van Hoef B; Collen D
    Eur J Biochem; 1987 Dec; 169(2):359-64. PubMed ID: 2961562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of immobilized bovine enterokinase in repetitive fusion protein cleavage for the production of mucin 1.
    Kubitzki T; Minör D; Mackfeld U; Oldiges M; Noll T; Lütz S
    Biotechnol J; 2009 Nov; 4(11):1610-8. PubMed ID: 19670252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covalent molecular weight approximately 92 000 hybrid plasminogen activator derived from human plasmin amino-terminal and urokinase carboxyl-terminal domains.
    Robbins KC; Tanaka Y
    Biochemistry; 1986 Jun; 25(12):3603-11. PubMed ID: 2941075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.